SARS-CoV-2-induced activation of pathogenic endogenous retrovirus envelope HERV-W: towards personalized treatment of COVID-19 patients

PDF icon final_version_4_6.pdf

Press release attached

Acronym: 
HERVCOV
Author: 
Schoorlemmer , Jon
Principal researcher: 
Branka Horvath
Managing entity: 
Otros
Scope: 
Internacional
Entidades participantes: 
INSERM
NKUA UNITOV IACS ARAID GNI IT FS CHCRI
UNITOV
GNI
FS CHCRI
CHCRI
IACS
ARAID
Number of researchers: 
7
Start date: 
07/2022
End date: 
06/2027
Entidad financiadora
Financing entity: 
Horizon Europe
Call: 
HORIZON-HLTH-2021-DISEASE-04
Presupuesto
Total budget: 
6.846.157€